메뉴 건너뛰기




Volumn 56, Issue 11, 2001, Pages 1505-1513

Randomized controlled trial of interferon-beta-1a in secondary progressive MS: MRI results

Author keywords

[No Author keywords available]

Indexed keywords

BETA1A INTERFERON; NEUTRALIZING ANTIBODY;

EID: 0035849494     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.56.11.1505     Document Type: Article
Times cited : (236)

References (18)
  • 1
    • 0001086743 scopus 로고    scopus 로고
    • PRISMS 4-year results: Evidence of clinical dose effect of interferon beta-1a in relapsing MS
    • PRISMS study group. Abstract
    • (2000) Neurology , vol.54 , pp. 2351
    • Freedman, M.S.1
  • 2
    • 0027418515 scopus 로고
    • Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial
    • (1993) Neurology , vol.43 , pp. 655-661
  • 5
    • 0345601517 scopus 로고    scopus 로고
    • Randomized double-blind placebo-controlled study of interferon-beta-1a in relapsing/remitting multiple sclerosis
    • (1998) Lancet , vol.352 , pp. 1498-1504
  • 6
    • 0032864616 scopus 로고    scopus 로고
    • Magnetic resonance imaging results of the PRISMS trial: A randomized, double-blind, placebo-controlled study of interferon-β1a in relapsing-remitting multiple sclerosis
    • (1999) Ann Neurol , vol.46 , pp. 197-206
    • Li, D.K.B.1    Paty, D.W.2
  • 7
    • 0032494792 scopus 로고    scopus 로고
    • Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis
    • (1998) Lancet , vol.352 , pp. 1491-1497
  • 8
    • 0033472729 scopus 로고    scopus 로고
    • Effect of interferon-β1b on magnetic resonance imaging outcomes in secondary progressive multiple sclerosis: Results of a European multicenter, randomized, double-blind, placebo-controlled trial
    • (1999) Ann Neurol , vol.46 , pp. 850-859
    • Miller, D.H.1    Molyneux, P.D.2    Barker, G.J.3
  • 9
    • 0035849496 scopus 로고    scopus 로고
    • Randomized controlled trial of interferon-beta-1a in secondary progressive MS: Clinical results
    • (2001) Neurology , vol.56 , pp. 1496-1504
  • 10
    • 0021035886 scopus 로고
    • Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
    • (1983) Neurology , vol.33 , pp. 1444-1452
    • Kurtzke, J.F.1
  • 12
    • 0004734975 scopus 로고
    • The comparison of more than two treatments
    • Lehmann EL, ed. San Francisco: Holden-Day, Inc., McGraw Hill
    • (1975) Nonparametrics , pp. 204-210
    • Lehmann, E.L.1
  • 13
    • 0000784055 scopus 로고    scopus 로고
    • Interferon beta-1b in secondary progressive MS: Clinical and MRI results of a 3-year randomized controlled trial
    • North American Study Group. Abstract
    • (2000) Neurology , vol.54 , pp. 2352-2352
    • Goodkin, D.E.1
  • 18
    • 0033586376 scopus 로고    scopus 로고
    • Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: A meta-analysis
    • (1999) Lancet , vol.353 , pp. 964-969
    • Kappos, L.1    Moeri, D.2    Radue, E.W.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.